[DEVELOPMENT OF FATAL IMMUNE CHECKPOINT INHIBITOR-ASSOCIATED ENCEPHALITIS FOLLOWING COMBINATION THERAPY WITH PEMBROLIZUMAB AND LENVATINIB IN A PATIENT WITH CLEAR CELL RENAL CELL CARCINOMA]
{{output}}
Immune checkpoint inhibitors (ICIs), a widely adopted therapeutic option for metastatic renal cell carcinoma, are also associated with a range of immune-related adverse events, some of which can be severe and life-threatening. Here, we describe the case of a 7... ...
